Studies stomach emptying and symptoms in people with gastric antral vascular ectasia
Measures stomach emptying and upper stomach symptoms in adults with gastric antral vascular ectasia.
Plain-language title generated from the registry record
Registry title: Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
Key facts
- Where
- Rochester, United StatesSee the site
Where in United States
- Mayo ClinicRochester, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Mayo Clinic
- Trial code
- NCT06306963
- Record updated
- 26 October 2026
- Original description
The researchers are trying to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, leading to their enlargement and possible bleeding. It can also cause symptoms such as abdominal pain and nausea. By participating in this study, you will help us learn how often these symptoms occur and how they relate to stomach functioning.Read full original descriptionShow less
Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
The researchers are trying to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, leading to their enlargement and possible bleeding. It can also cause symptoms such as abdominal pain and nausea. By participating in this study, you will help us learn how often these symptoms occur and how they relate to stomach functioning.
Inclusion: Patients >18 years of age with endoscopic evidence of Gastric Antral Vascular Ectasia; Willingness to participate in the study; Capacity to provide informed consent; No evidence of organic, systemic, or metabolic disease (e.g. diabetes mellitus) to explain the symptoms on routine investigations.
Exclusion: Patients with severe decompensated liver disease; Patients with end stage renal disease; Presence of other diseases (structural or metabolic) which could interfere with interpretation of the study results; Patients with transfusion dependent blood loss; Pregnant or lactating women; Patients who have not had a CBC and differential blood draw completed within the last six months; Current heavy alcohol use.